L 783281

Drug Profile

L 783281

Alternative Names: Demethylasterriquinone B1

Latest Information Update: 30 Mar 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Merck & Co
  • Developer Duke University; Merck & Co
  • Class Antihyperglycaemics; Indoles
  • Mechanism of Action Protein tyrosine kinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Neurological disorders; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Most Recent Events

  • 03 Oct 2005 A preclinical study has been added to the Diabetes pharmacodynamics section
  • 20 May 2003 No development reported - Preclinical for Type-1 diabetes mellitus in USA (PO)
  • 20 May 2003 No development reported - Preclinical for Type-2 diabetes mellitus in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top